MetaCap

U.S. Physical Therapy Inc. (USPH)

NYSE: USPHHealth CareMedical/Nursing ServicesUSD

95.93+1.61 (+1.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

USPH stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$1.33
Dividend yield
1.91% ($1.83)
Ex-dividend date
Nov 16, 2026
52-week range
58.19 – 101.80
Day range
94.99 – 96.76
Volume / Avg
209.71K / 186.22K
Beta
—

52-week range

$58.19$101.80

USPH stock today

Shares of U.S. Physical Therapy (USPH) finished higher on Nov 20 at $95.93, a gain of 1.71% or $1.61 per share, versus the S&P 500's 3.70% decline. At this level, USPH sits near the top of its 52-week range of $58.19 to $101.80: 5.8% below the high, set on Nov 12, 2026 and 64.9% above the low. USPH is up 22.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 33.9%.

U.S. Physical Therapy has posted a net loss over the last twelve months (EPS of -$1.33), so its P/E ratio is not meaningful. U.S. Physical Therapy pays an annual dividend of $1.83 per share, a 1.91% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About U.S. Physical Therapy

Company profile

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services.

Industry
Medical/Nursing Services
CEO
Mr. Christopher J. Reading
Headquarters
Houston, TX
Employees
4,653
IPO year
1992
Website
usph.com

Financial highlights

Full financials

In fiscal 2025, U.S. Physical Therapy generated $781.0 million in revenue, up 16.3% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $39.6 million (+26.0% year over year), for a net margin of 5.1% versus a median of 5.8% in the prior 5 years. Gross margin was 19.2% (up from 18.5%) and operating margin 11.1%.

U.S. Physical Therapy annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$780.99M$671.35M$604.80M$553.14M$495.02M
Growth+16.33%+11.00%+9.34%+11.74%+17.04%
Net income$39.58M$31.42M$28.24M$32.16M$40.83M
EPS (diluted)$1.42$1.84$1.28$2.25$2.41

Analyst forecast

Forecast

Consensus (7 analysts)

buy

Avg. price target

$111.50+16.23%

  • Strong buy 4
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $95.00High $122.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.66 vs $0.76
Surprise
-13.16%

Dividends

Dividend history
Annual dividend
$1.83
Last payment
$0.46
Ex-dividend date
Nov 16, 2026

USPH news

All USPH news

U.S. Physical Therapy peers

Health Care sector
USPH peer companies
CompanyPrice% ChgMarket capCompare
WGSGeneDx Holdings Corp. Class A45.46-7.68%$1.36Bvs USPH
TDOCTeladoc Health Inc.7.45-4.36%$1.36Bvs USPH
INNVInnovAge Holding Corp.9.16+2.81%$1.25Bvs USPH
PNTGThe Pennant Group Inc.34.64+1.61%$1.22Bvs USPH
AHCOAdaptHealth Corp.7.20-0.69%$982.98Mvs USPH
OMDAOmada Health Inc.11.87-5.04%$736.39Mvs USPH
ADUSAddus HomeCare Corporation122.50+1.18%$2.28Bvs USPH
SBCSBC Medical Group Holdings Incorporated5.17-7.68%$530.32Mvs USPH

Indexes, lists and sector

U.S. Physical Therapy stock FAQ

What is U.S. Physical Therapy's stock price today?

USPH last traded at $95.93 as of Nov 20, 4:00 PM EST, up 1.71% on the day. Prices are delayed at least 15 minutes.

Does U.S. Physical Therapy pay a dividend?

Yes. U.S. Physical Therapy pays $1.83 per share annually, a 1.91% yield. The most recent dividend of $0.46 had an ex-dividend date of Nov 16, 2026.

Who is U.S. Physical Therapy's CEO?

Mr. Christopher J. Reading is the chief executive officer of U.S. Physical Therapy Inc., which has about 4,653 employees.

Has USPH ever split its stock?

Yes. The most recent USPH stock split was a 3-for-2 split on Jun 29, 2001, one of 2 splits on record.

What is the USPH 52-week high?

The 52-week high for USPH is $101.80 and the 52-week low is $58.19. The stock is currently 5.8% below its high.

Compare USPH